Radiation oncology has the potential to be an excellent option for the frail elderly cancer patients because of its limited systemic toxicities. It can be effective for curative, prophylactic, disease control or palliative purposes. Currently about 60% of all cancer patients undergoing active treatment at some point receive radiation treatment. However, though widely used, there are limited clinical trials strictly designed for the elderly. This paper will review the key points in the assessment and treatment of elderly cancer patient including quality of life, active life expectancy, cognitive performance, frailty, sarcopenia and how the new technologies can help to reach the key goal of maintaining autonomy and independence for the elderly cancer patient.
Colloca, G., Tagliaferri, L., Capua, B. D., Gambacorta, M. A., Lanzotti, V., Bellieni, A., Monfardini, S., Balducci, L., Bernabei, R., Cho, W. C., Valentini, V., Management of the elderly cancer patients complexity: The radiation oncology potential, <<AGING AND DISEASE>>, 2020; 11 (3): 649-657. [doi:10.14336/AD.2019.0616] [http://hdl.handle.net/10807/178039]
Management of the elderly cancer patients complexity: The radiation oncology potential
Colloca, G.;Tagliaferri, L.;Gambacorta, M. A.;Bellieni, A.;Bernabei, R.;Valentini, V.
2020
Abstract
Radiation oncology has the potential to be an excellent option for the frail elderly cancer patients because of its limited systemic toxicities. It can be effective for curative, prophylactic, disease control or palliative purposes. Currently about 60% of all cancer patients undergoing active treatment at some point receive radiation treatment. However, though widely used, there are limited clinical trials strictly designed for the elderly. This paper will review the key points in the assessment and treatment of elderly cancer patient including quality of life, active life expectancy, cognitive performance, frailty, sarcopenia and how the new technologies can help to reach the key goal of maintaining autonomy and independence for the elderly cancer patient.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.